Amphotericin B: An update

British Journal of Biomedical Science

Volumn 53, Issue 2, 1996, Pages 122-133

  Abu Salah, Khalid M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Amphotericin B; Antibiotics, antifungal; Immune system; Ionophores; Liposomes; Polyenes; Spectrometry, fluoresence

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ERGOSTEROL; MACROLIDE;

ANTIFUNGAL ACTIVITY; DRUG BINDING; DRUG MECHANISM; MEMBRANE PERMEABILITY; MYCOSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; DRUG CARRIERS; DRUG SYNERGISM; HUMANS; IMMUNE SYSTEM; LIPOSOMES;

EID: 0029955890     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. Borowski E, Zeilinski J, Ziminski T et al. Chemical studies with amphotericin B. III. The complete structure of the antibiotic. Tetrahedron Lett 1970; 45:3909-14.
2. Lopez-Berestein G, Bodey GP, Frankel LS, Mehta K. Treatment of hepatosplenic fungal infections with liposomal-amphotericin B. J Clin Oncol 1987; 5:310-17.
3. Lopez-Berestein G, Feistein V, Hopfer RL et al. Liposomalamphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary report. J Infect Dis 1985; 4: 704-10.